Impact of thoracic radiotherapy on first-line treatment outcomes in ES-SCLC patients.

Thus, weconfirmed that the addition of tRT to the conventional regimen of first-linechemotherapy and immunotherapy yields better survival outcomes without asignificant increase in toxicity.